Suprabhat Mukherjee - Search Results

Year	Number of Results
2012	1
2013	1
2014	6
2015	3
2016	4
2017	3
2018	4
2019	4
2020	3
2021	9
2022	8
2023	12
2024	1

1

Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives.

Mukherjee S, Patra R, Behzadi P, Masotti A, Paolini A, Sarshar M. Mukherjee S, et al. Front Immunol. 2023 Sep 26;14:1244345. doi: 10.3389/fimmu.2023.1244345. eCollection 2023. Front Immunol. 2023. PMID: 37822929 Free PMC article. Review.

2

Toll-like receptor 4 in COVID-19: friend or foe?

Mukherjee S. Mukherjee S. Future Virol. 2022 Mar:10.2217/fvl-2021-0249. doi: 10.2217/fvl-2021-0249. Epub 2022 Apr 19. Future Virol. 2022. PMID: 35462619 Free PMC article.

3

DPP-4 Inhibitors as a savior for COVID-19 patients with diabetes.

Nag S, Mandal S, Mukherjee O, Mukherjee S, Kundu R. Nag S, et al. Among authors: mukherjee s. Future Virol. 2023 Mar:10.2217/fvl-2022-0112. doi: 10.2217/fvl-2022-0112. Epub 2023 Apr 11. Future Virol. 2023. PMID: 37064327 Free PMC article. Review.

4

Chemotherapy vs. Immunotherapy in combating nCOVID19: An update.

Choudhury A, Mukherjee G, Mukherjee S. Choudhury A, et al. Among authors: mukherjee s. Hum Immunol. 2021 Sep;82(9):649-658. doi: 10.1016/j.humimm.2021.05.001. Epub 2021 May 18. Hum Immunol. 2021. PMID: 34020832 Free PMC article. Review.

5

Immunoinformatics Approaches in Designing Vaccines Against COVID-19.

Chakraborty A, Bayry J, Mukherjee S. Chakraborty A, et al. Among authors: mukherjee s. Methods Mol Biol. 2023;2673:431-452. doi: 10.1007/978-1-0716-3239-0_29. Methods Mol Biol. 2023. PMID: 37258931

6

Programmed cell death pathways as targets for developing antifilarial drugs: Lessons from the recent findings.

Das NC, Chakraborty P, Nandy S, Dey A, Malik T, Mukherjee S. Das NC, et al. Among authors: mukherjee s. J Cell Mol Med. 2023 Oct;27(19):2819-2840. doi: 10.1111/jcmm.17913. Epub 2023 Aug 22. J Cell Mol Med. 2023. PMID: 37605891 Free PMC article. Review.

7

Gut microbes as future therapeutics in treating inflammatory and infectious diseases: Lessons from recent findings.

Mukherjee S, Joardar N, Sengupta S, Sinha Babu SP. Mukherjee S, et al. J Nutr Biochem. 2018 Nov;61:111-128. doi: 10.1016/j.jnutbio.2018.07.010. Epub 2018 Aug 16. J Nutr Biochem. 2018. PMID: 30196243 Free PMC article. Review.

8

Toll-like receptor polymorphism in host immune response to infectious diseases: A review.

Mukherjee S, Huda S, Sinha Babu SP. Mukherjee S, et al. Scand J Immunol. 2019 Jul;90(1):e12771. doi: 10.1111/sji.12771. Epub 2019 May 20. Scand J Immunol. 2019. PMID: 31054156 Free article. Review.

9

Metabolic Inhibitors as Antiparasitic Drugs: Pharmacological, Biochemical and Molecular Perspectives.

Mukherjee S, Mukherjee N, Gayen P, Roy P, Babu SP. Mukherjee S, et al. Curr Drug Metab. 2016;17(10):937-970. doi: 10.2174/1389200217666161004143152. Curr Drug Metab. 2016. PMID: 27719626 Review.

10

Helminth-derived biomacromolecules as therapeutic agents for treating inflammatory and infectious diseases: What lessons do we get from recent findings?

Chakraborty P, Aravindhan V, Mukherjee S. Chakraborty P, et al. Among authors: mukherjee s. Int J Biol Macromol. 2023 Jun 30;241:124649. doi: 10.1016/j.ijbiomac.2023.124649. Epub 2023 Apr 28. Int J Biol Macromol. 2023. PMID: 37119907 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

51 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year